Notes
2015 pharmacy retail price
2013 euros
Reference
Christensen H, et al. Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero to reduce meningococcal group B disease in Germany. Vaccine : 12 Apr 2016. Available from: URL: http://doi.org/10.1016/j.vaccine.2016.04.004
Rights and permissions
About this article
Cite this article
Universal Bexsero vaccination not cost effective in Germany. PharmacoEcon Outcomes News 752, 33 (2016). https://doi.org/10.1007/s40274-016-3027-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3027-z